Rising dangers for aid workers in Lebanon amid Israel-Hezbollah hostilities
Compare the reporting
Significant discrepancy in the nature of targets and scale of destruction.
Open the listed sources to review each publisher’s original wording.
Story essentials
Lebanese Red Cross, WHO, OHCHR
Lebanon
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policyRead next
Prioritized by shared people, places, and events.
Oxford University begins clinical trials for Bundibugyo Ebola vaccine
Oxford University has administered the first dose of a vaccine targeting the Bundibugyo strain of Ebola. The outbreak in DRC and Uganda has caused over 1,270 deaths and nearly 3,000 infections since May. The vaccine candidate was developed in eight weeks using technology similar to the AstraZeneca Covid-19 vaccine. WHO warns that the actual number of cases could be twice as high due to conflict-related access issues.
Related book
Hizbullah: The Story from Within
Author: Naim Qassem
This book provides an insider's perspective on the ideology, organizational structure, and strategic motivations of Hezbollah, which is essential for understanding the group's role in the ongoing conflict and its complex relationship with the Lebanese state and international actors.
As an Amazon Associate, COMPAMIR earns from qualifying purchases.